Therapeutic Transplantation of Human Central Nervous System Organoids for Neural Reconstruction

Author:

Hong Sung Jun12ORCID,Bock Minsung3ORCID,Zhang Songzi3ORCID,An Seong Bae3,Han Inbo3ORCID

Affiliation:

1. Research Competency Milestones Program (RECOMP), School of Medicine, CHA University, Seongnam-si 13488, Republic of Korea

2. Department of Medicine, School of Medicine, CHA University, Seongnam-si 13496, Republic of Korea

3. Department of Neurosurgery, CHA Bundang Medical Center, CHA University, Seongnam-si 13496, Republic of Korea

Abstract

Damage to the central nervous system (CNS) often leads to irreversible neurological deficits, and there are currently few effective treatments available. However, recent advancements in regenerative medicine have identified CNS organoids as promising therapeutic options for addressing CNS injuries. These organoids, composed of various neurons and supporting cells, have shown potential for direct repair at injury sites. CNS organoids resemble the structure and function of actual brain tissue, which allows them to adapt and function well within the physiological environment when transplanted into injury sites. Research findings suggest that CNS organoids can replace damaged neurons, form new neural connections, and promote neural recovery. This review highlights the emerging benefits, evaluates preclinical transplantation outcomes, and explores future strategies for optimizing neuroregeneration using CNS organoids. With continued research and technological advancements, these organoids could provide new hope for patients suffering from neurological deficits.

Funder

National Research Foundation of Korea

Publisher

MDPI AG

Reference88 articles.

1. Traumatic brain injury: Progress and challenges in prevention, clinical care, and research;Maas;Lancet Neurol.,2022

2. Lu, Y., Shang, Z., Zhang, W., Pang, M., Hu, X., Dai, Y., Shen, R., Wu, Y., Liu, C., and Luo, T. (2024). Global incidence and characteristics of spinal cord injury since 2000–2021: A systematic review and meta-analysis. BMC Med., 22.

3. GBD 2016 Neurology Collaborators (2019). Global, regional, and national burden of neurological disorders, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol, 18, 459–480.

4. Challenges in the search for drugs to treat central nervous system disorders;Enna;J. Pharmacol. Exp. Ther.,2009

5. Intravenous mesenchymal stem cell therapy for traumatic brain injury;Harting;J. Neurosurg.,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3